IHA Letter Urges Opposition to Section 203 of Lower Costs, More Transparency Act

IHA opposes Section 203 of the Lower Costs, More Transparency Act, which would implement harmful site-neutral payment cuts for drug services administered in off-campus, provider-based departments.